O. Lambotte, F. Boufassa, Y. Madec, A. Nguyen, C. Goujard et al., HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication, Clinical Infectious Diseases, vol.41, issue.7, pp.1053-1056, 2005.
DOI : 10.1086/433188

S. Deeks and B. Walker, Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy, Immunity, vol.27, issue.3, pp.406-416, 2007.
DOI : 10.1016/j.immuni.2007.08.010

B. Emu, E. Sinclair, D. Favre, W. Moretto, P. Hsue et al., Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment, Journal of Virology, vol.79, issue.22, pp.14169-14178, 2005.
DOI : 10.1128/JVI.79.22.14169-14178.2005

A. Lamine, A. Caumont-sarcos, M. Chaix, A. Saez-cirion, C. Rouzioux et al., Replication-competent HIV strains infect HIV controllers despite undetectable viremia
DOI : 10.1097/qad.0b013e3280d5a7ac
URL : https://hal.archives-ouvertes.fr/hal-00166186

A. Sáez-cirión, C. Lacabaratz, O. Lambotte, P. Versmisse, A. Urrutia et al., HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype, Proceedings of the National Academy of Sciences, vol.104, issue.16, pp.6776-6781, 2007.
DOI : 10.1073/pnas.0611244104

S. Migueles, C. Osborne, C. Royce, A. Compton, R. Joshi et al., Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control, Immunity, vol.29, issue.6, 2008.
DOI : 10.1016/j.immuni.2008.10.010

Z. Ndhlovu, L. Chibnik, J. Proudfoot, S. Vine, A. Mcmullen et al., High-dimensional immune monitoring models of HIV-1-specific CD8 T cell responses accurately identify subjects achieving

M. Betts, M. Nason, S. West, D. Rosa, S. Migueles et al., HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells, Blood, vol.107, issue.12, pp.4781-4789, 2006.
DOI : 10.1182/blood-2005-12-4818

B. Vingert, S. Perez-patrigeon, P. Jeannin, O. Lambotte, F. Boufassa et al., HIV Controller CD4+ T Cells Respond to Minimal Amounts of Gag Antigen Due to High TCR Avidity, PLoS Pathogens, vol.77, issue.2, p.20195518, 2010.
DOI : 10.1371/journal.ppat.1000780.s007

A. Sáez-cirión, G. Pancino, M. Sinet, A. Venet, and O. Lambotte, HIV controllers: how do they tame the virus?, Trends in Immunology, vol.28, issue.12, pp.532-540, 2007.
DOI : 10.1016/j.it.2007.09.002

F. Boufassa, A. Saez-cirion, J. Lechenadec, D. Zucman, V. Avettand-fenoel et al., CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory, PLoS ONE, vol.4, issue.9, p.21533035, 2011.
DOI : 10.1371/journal.pone.0018726.t002
URL : https://hal.archives-ouvertes.fr/pasteur-01420582

F. Boufassa, J. Lechenadec, L. Meyer, D. Costagliola, P. Hunt et al., Blunted Response to Combination Antiretroviral Therapy in HIV Elite Controllers: An International HIV Controller Collaboration, PLoS ONE, vol.9, issue.3, p.24465584, 2014.
DOI : 10.1371/journal.pone.0085516.s001
URL : https://hal.archives-ouvertes.fr/hal-01344809

H. Hatano, E. Delwart, P. Norris, T. Lee, J. Dunn-williams et al., Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral Therapy, Journal of Virology, vol.83, issue.1, pp.329-335, 2009.
DOI : 10.1128/JVI.01763-08

P. Hunt, J. Brenchley, E. Sinclair, J. Mccune, R. M. Page-shafer et al., T Cell Count in HIV???Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy, The Journal of Infectious Diseases, vol.197, issue.1, pp.126-133, 2008.
DOI : 10.1086/524143

N. Noel, F. Boufassa, C. Lécuroux, A. Saez-cirion, C. Bourgeois et al., Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients, AIDS, vol.28, issue.4, pp.467-476, 2014.
DOI : 10.1097/QAD.0000000000000174
URL : https://hal.archives-ouvertes.fr/pasteur-01420524

F. Pereyra, J. Lo, V. Triant, J. Wei, M. Buzon et al., Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers, AIDS, vol.26, issue.18, pp.2409-2412, 2012.
DOI : 10.1097/QAD.0b013e32835a9950

P. Hsue, P. Hunt, A. Schnell, S. Kalapus, R. Hoh et al., Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis, AIDS, vol.23, issue.9, pp.1059-1067, 2009.
DOI : 10.1097/QAD.0b013e32832b514b

Y. Madec, F. Boufassa, K. Porter, M. Prins, C. Sabin et al., Natural history of HIV-control since seroconversion, AIDS, vol.27, issue.15, pp.2451-2460, 2013.
DOI : 10.1097/01.aids.0000431945.72365.01

A. Sedaghat, D. Rastegar, O. Connell, K. Dinoso, J. Wilke et al., T Cell Dynamics and the Response to HAART in a Cohort of HIV???1???Infected Elite Suppressors, Clinical Infectious Diseases, vol.49, issue.11, pp.1763-1766, 2009.
DOI : 10.1086/648081

J. Okulicz, V. Marconi, M. Landrum, S. Wegner, A. Weintrob et al., Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long???Term Nonprogressors in the US Department of Defense HIV Natural History Study, The Journal of Infectious Diseases, vol.200, issue.11, pp.1714-1723, 2009.
DOI : 10.1086/646609

K. Groves, D. Bibby, D. Clark, A. Isaksen, J. Deayton et al., Disease Progression in HIV-1???Infected Viremic Controllers, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.61, issue.4, pp.407-416, 2012.
DOI : 10.1097/QAI.0b013e318269c414

M. Sajadi, R. Pulijala, R. Redfield, and R. Talwani, Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors, AIDS, vol.26, issue.15, pp.1879-1884, 2012.
DOI : 10.1097/QAD.0b013e328357f5d1

E. Ruiz-mateos, K. Machmach, M. Romero-sanchez, S. Ferrando-martinez, P. Viciana et al., Hepatitis C virus replication in Caucasian HIV controllers, Journal of Viral Hepatitis, vol.16, issue.1, pp.350-357, 2011.
DOI : 10.1111/j.1365-2893.2010.01431.x

A. Rachinger, M. Navis, S. Van-assen, P. Groeneveld, and H. Schuitemaker, Recovery of Viremic Control after Superinfection with Pathogenic HIV Type 1 in a Long???Term Elite Controller of HIV Type 1 Infection, Clinical Infectious Diseases, vol.47, issue.11, pp.86-89, 2008.
DOI : 10.1086/592978

O. Clerc, S. Colombo, S. Yerly, A. Telenti, and M. Cavassini, HIV-1 elite controllers: Beware of super-infections, Journal of Clinical Virology, vol.47, issue.4
DOI : 10.1016/j.jcv.2010.01.013

O. Lambotte, C. Lecuroux, A. Saez-cirion, C. Barbet, S. Shin et al., Kidney transplantation in an elite HIV controller: Limited impact of immunosuppressive therapy on viro-immunological status, Journal of Infection, vol.64, issue.6, pp.630-633, 2012.
DOI : 10.1016/j.jinf.2012.03.001
URL : https://hal.archives-ouvertes.fr/pasteur-01420580

C. Lécuroux, A. Sáez-cirión, I. Girault, P. Versmisse, F. Boufassa et al., Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV-Specific CD8+ T Cell Response in HIV Controllers, Journal of Virology, vol.88, issue.1, pp.176-187, 2014.
DOI : 10.1128/JVI.02098-13

V. Avettand-fènoël, M. Chaix, S. Blanche, M. Burgard, C. Floch et al., LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01), J Med Virol, vol.81, pp.217-223, 2009.

A. Sáez-cirión, M. Sinet, S. Shin, A. Urrutia, P. Versmisse et al., Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses, The Journal of Immunology, vol.182, issue.12, pp.7828-7837, 2009.
DOI : 10.4049/jimmunol.0803928

A. Sáez-cirión, S. Shin, P. Versmisse, F. Barré-sinoussi, and G. Pancino, Ex vivo T cell???based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses, Nature Protocols, vol.178, issue.6, pp.1033-1041, 2010.
DOI : 10.1038/nprot.2006.268

F. Pereyra, S. Palmer, T. Miura, B. Block, A. Wiegand et al., Persistent Low???Level Viremia in HIV???1 Elite Controllers and Relationship to Immunologic Parameters, The Journal of Infectious Diseases, vol.200, issue.6, pp.984-990, 2009.
DOI : 10.1086/605446

P. Morlat, Prise en charge médicale des personnes vivant avec le VIH. Recommandations du groupe d'experts, 2013.

H. Hatano, S. Yukl, A. Ferre, E. Graf, M. Somsouk et al., Prospective Antiretroviral Treatment of Asymptomatic, HIV-1 Infected Controllers, PLoS Pathogens, vol.3, issue.10, p.24130489, 2013.
DOI : 10.1371/journal.ppat.1003691.t001

J. Okulicz, G. Grandits, A. Weintrob, M. Landrum, A. Ganesan et al., CD4 T Cell Count Reconstitution in HIV Controllers after Highly Active Antiretroviral Therapy, Clinical Infectious Diseases, vol.50, issue.8, pp.1187-1191, 2010.
DOI : 10.1086/651421

D. Gurdasani, L. Iles, D. Dillon, E. Young, A. Olson et al., A systematic review of definitions of extreme phenotypes of HIV control and progression, AIDS, vol.28, issue.2, pp.149-162, 2014.
DOI : 10.1097/QAD.0000000000000049

A. Olson, L. Meyer, M. Prins, R. Thiebaut, D. Gurdasani et al., An Evaluation of HIV Elite Controller Definitions within a Large Seroconverter Cohort Collaboration, PLoS ONE, vol.50, issue.1, p.24489776, 2014.
DOI : 10.1371/journal.pone.0086719.s001
URL : https://hal.archives-ouvertes.fr/hal-01368387